Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eurofins Scientific (FR:ERF)
PARIS:ERF
Holding FR:ERF?
Track your performance easily
ERF Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€39.47 - €62.10
Previous Close€47.96
Volume188.37K
Average Volume (3M)398.99K
Market Cap
€9.26B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)24.3
Beta0.96
Next Earnings
Mar 04, 2025EPS Estimate
€1.63Last Dividend Ex-Date
Jul 03, 2024Dividend Yield1.05%
Share Statistics
EPS (TTM)1.97
Shares OutstandingN/A
10 Day Avg. Volume351,270
30 Day Avg. Volume398,989
Standard Deviation0.09
R-Squared0.10
Alpha0.00212
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)1.83
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€64.04Price Target Upside31.81% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Options Prices
Currently, No data available
---
Ownership Overview
33.86% Insiders
12.92% Mutual Funds
― Other Institutional Investors
46.98% Public Companies and
Individual Investors
ERF FAQ
What was Eurofins Scientific’s price range in the past 12 months?
Eurofins Scientific lowest stock price was €39.47 and its highest was €62.10 in the past 12 months.
What is Eurofins Scientific’s market cap?
Currently, no data Available
When is Eurofins Scientific’s upcoming earnings report date?
Eurofins Scientific’s upcoming earnings report date is Mar 04, 2025 which is in 70 days.
How were Eurofins Scientific’s earnings last quarter?
Eurofins Scientific released its earnings results on Jul 24, 2024. The company reported €1.25 earnings per share for the quarter, the consensus estimate of €1.25 by €0.
Is Eurofins Scientific overvalued?
According to Wall Street analysts Eurofins Scientific’s price is currently Undervalued.
Does Eurofins Scientific pay dividends?
Eurofins Scientific pays a Annually dividend of €0.5 which represents an annual dividend yield of 1.05%. See more information on Eurofins Scientific dividends here
What is Eurofins Scientific’s EPS estimate?
Eurofins Scientific’s EPS estimate is €1.63.
How many shares outstanding does Eurofins Scientific have?
Eurofins Scientific has 192,981,190 shares outstanding.
What happened to Eurofins Scientific’s price movement after its last earnings report?
Eurofins Scientific reported an EPS of €1.25 in its last earnings report, expectations of €1.25. Following the earnings report the stock price went up 3.333%.
Which hedge fund is a major shareholder of Eurofins Scientific?
Currently, no hedge funds are holding shares in FR:ERF
---
Eurofins Scientific Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€64.04 (31.81% Upside)
€64.04 (31.81% Upside)
Insider Transactions
Bought Shares
Worth €11.8M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.69%
12-Months-Change
Fundamentals
Return on Equity
9.21%
Trailing 12-Months
Asset Growth
4.65%
Trailing 12-Months
Company Description
Eurofins Scientific
Eurofins, headquartered in Luxembourg, has three main business lines: food and environment testing, services to pharmaceutical and biotechnology companies, and clinical diagnostics, with the three segments contributing about 42%, 33%, and 20% of revenue, respectively. Through its subsidiaries, Eurofins provides various analytical testing and laboratory services on a global scale, and the company offers testing options for evaluating the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products. The company also has a growing clinical diagnostics unit, with specialties in infectious diseases, prenatal screening, and organ transfer. Eurofins operates over 800 laboratories in 50 countries.
---
ERF Stock 12 Month Forecast
Average Price Target
€64.04
▲(31.81% Upside)
Technical Analysis
GlaxoSmithKline
―
Hikma Pharmaceuticals
―
PureTech Health
―
Scancell Holdings
―
Eurofins Scientific
―
Best Analysts Covering ERF
1 Year
1 Year Success Rate
4/6 ratings generated profit
1 Year Average Return
+4.67%
reiterated a sell rating 2 months ago
Copying Allen Wells's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +4.67% per trade.
---